ASH 43rd (2001)

Title Content type
Autologous Stem Cell Transplants Combined with Rituximab for Relapsed Follicular Lymphoma Achieve Prolonged Clinical and Molecular Remissions. (click for details)
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis. (click for details)
Elderly Patients with Aggressive Non-Hodgkin's Lymphoma (NHL): An Age Adjusted High Dose Chemotherapy (HDC) with Autologous Stem Cell Transplantation (ASCT) Allows an Adequate PBPC Yield with Low Toxicity and Promising Results. (click for details)
Post-Transplant Thrombotic Thrombocytopenic Purpura (TTP), a Complication of High Risk Myeloablative and Non-Myeloablative Transplantation, Is Not Associated with von Willebrand Factor-Cleaving Protease (vWF-CP) Deficiency. (click for details)
Stem Cell Transplantation (SCT) after Successful Therapy with Glivec(STI571) for Poor-Prognosis Ph1-Positive (Ph1+) Malignancies. (click for details)
Autologous Cord Blood Infusion for Severe Aplastic Anemia (SAA). (click for details)
Yield of Surveillance Blood Cultures in Patients on Corticosteroids for Graft-Versus-Host Disease. (click for details)
Early Introduction of FK506 followed by MMF in Non-Myeloablative Hematopoietic Stem Cell Allotransplantation (NMA-HSCAT) leads to Prompt Engraftment without Acute GVHD. (click for details)
Total Marrow Irradiation, Bubulfan and Cyclophosphamide Followed by PBSCT in Patients with Advanced Multiple Myeloma. (click for details)
Tacrolimus (FK506) and Mycophenolate Mofetil (MMF) Is a Safe and Potentially Effective Alternative GVHD Prophylaxis Regimen in Related (R) and Unrelated (UR) Donor Allogeneic SCT (AlloSCT). (click for details)

Pages

Subscribe to ASH 43rd (2001)